The other essential fatty acid family. You need omega-6s, but most people already get plenty from their diet. Provides essential fatty acids for cell membranes, brain function, and immune signaling
Reviewed March 2026
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Total Omega-6s has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Linoleic acid is the parent 18-carbon omega-6 and makes up the large majority of omega-6 intake. Everything downstream in the class starts from it.
Delta-6 desaturase converts linoleic acid to gamma-linolenic acid, the first committed step of the omega-6 chain. Supplying GLA directly bypasses a step that is often slow.
Linoleic acid elongates and desaturates through dihomo-gamma-linolenic acid to arachidonic acid, the 20-carbon omega-6 that feeds cyclooxygenase and lipoxygenase signalling. Total omega-6 intake sets the size of that pool.
Omega-6 and omega-3 fatty acids are handled by the same delta-6 desaturase, elongase and delta-5 desaturase enzymes, so a high omega-6 load slows conversion of alpha-linolenic acid onward. They also compete for the same positions in membrane phospholipids.
EPA and arachidonic acid compete for the same cyclooxygenase and lipoxygenase enzymes, and the mediators each produces differ in signalling strength. The ratio of the two in membrane phospholipids is what shapes the output.
DHA and omega-6 fatty acids compete for the sn-2 position of membrane phospholipids, so a heavy omega-6 supply lowers DHA incorporation at the same intake. Tissue composition reflects the balance rather than either alone.
Marine EPA and DHA displace omega-6 fatty acids from tissue phospholipids in a dose-dependent way. Formulas that carry a large omega-6 load blunt how far a given fish oil dose shifts membrane composition.
Alpha-linolenic acid from flax must pass through the same delta-6 desaturase that linoleic acid occupies, and linoleic acid is usually present in far greater amounts. A high omega-6 background lowers the fraction of ALA that reaches EPA.
Polyunsaturated fatty acids carry bis-allylic hydrogens that are readily abstracted, so tissue requirement for alpha-tocopherol rises with the amount of omega-6 in the diet. Tocopherol chain-breaks the peroxidation those double bonds start.
A full tocopherol spectrum protects unsaturated oils in the capsule and contributes to lipid peroxidation defence in membranes. Gamma-tocopherol in particular handles nitrogen-derived oxidants that alpha-tocopherol handles poorly.
Carnosic acid and rosmarinic acid from rosemary are the standard natural antioxidants used to hold polyunsaturated oils against rancidity. They protect the oil in the finished product rather than acting in the body.
Delta-6 desaturase activity depends on adequate zinc, and low zinc status slows conversion of linoleic acid onward. The bottleneck shows as accumulated parent fatty acid with little downstream product.
Borage oil is roughly a fifth gamma-linolenic acid alongside a large linoleic acid fraction, so it adds directly to total omega-6 intake. It supplies the pathway past its slowest step.
Evening primrose oil is mostly linoleic acid with about a tenth gamma-linolenic acid. Counting it toward total omega-6 matters because it shifts the same n-6 to n-3 balance.
Conjugated linoleic acid isomers compete with ordinary linoleic acid for desaturation and for incorporation into tissue lipids. The trans-10, cis-12 isomer in particular alters how the parent omega-6 is handled.
Delta-6 desaturase is the rate-limiting step that converts linoleic acid onward to gamma-linolenic acid, and its activity depends on adequate pyridoxine along with zinc and magnesium. Where any of those is short, more of the dietary linoleic acid stays as linoleic acid. This is enzyme biochemistry rather than a measured supplement effect.
Magnesium is required for the desaturase and elongase steps that extend and unsaturate the omega-6 chain. Its role is a general cofactor requirement across fatty acid metabolism. Nothing here says supplementing magnesium raises conversion in a person with adequate status.
Glutathione peroxidases are selenoenzymes, and glutathione peroxidase 4 is the one that reduces lipid hydroperoxides inside membranes. Polyunsaturated fats are the substrate that generates those hydroperoxides. More polyunsaturated fat in a membrane raises the demand on that repair system.
Ascorbate regenerates the tocopheroxyl radical formed when vitamin E stops a lipid peroxidation chain in a membrane rich in polyunsaturated fat. The water-soluble and fat-soluble antioxidants work as one network at the membrane surface. This is recycling chemistry, not a claim about an outcome.
Astaxanthin spans the lipid bilayer with polar ends at both surfaces, which is the geometry that lets it intercept radicals within the membrane. Polyunsaturated fatty acids are the most oxidisable component of that membrane. The pairing rests on membrane chemistry rather than on a trial of the combination.
Chain-breaking antioxidants of the vitamin E family are added to polyunsaturated oils both in the bottle and in the body, because each double bond is a site where peroxidation can start. Seed oils naturally carry some vitamin E for this reason. The relationship protects the fat rather than amplifying its effect.
Reduced coenzyme Q10 acts as a lipid-phase antioxidant and regenerates alpha-tocopherol within the membrane. In an oil formulation it also slows oxidation of the carrier. The role is protective chemistry within the lipid phase.
Arachidonic acid, the downstream omega-6 metabolite, is the substrate cyclooxygenase uses to make thromboxane A2 in platelets, and salicylates act on that same enzyme. The two therefore pull on the same pathway in opposite directions. Anyone already on a platelet-affecting medication should raise this with their clinician.
Phospholipids from seed sources are themselves rich in linoleic acid and act as emulsifiers in a softgel or emulsion. They keep the oil phase dispersed and slow separation. This is a formulation role, not a metabolic one.
Talk to a doctor before taking Total Omega-6s if any of these apply to you: Most people get too much omega-6 already, Can worsen inflammation if ratio to omega-3 is poor, Supplementation rarely needed. These are flags to check first, not effects Total Omega-6s is known to cause.
Not medical advice. Show the label to your pharmacist.The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
These are the studies our verdict leans on, chosen from the 4 we read for Total Omega-6s. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.